Press release
Complex Regional Pain Syndrome (CRPS) Therapeutics Clinical Trials & Results | Axsome Therapeutics, Inc., Grünenthal Group
Download the sample report @ https://www.pharmaproff.com/request-sample/1096
CRPS is categorized into two main types: CRPS-I and CRPS-II. CRPS-I is associated with unconfirmed nerve injury; whereas, CRPS-II is associated with confirmed nerve injury. CRPS can be characterized by ‘pins and needles’, or ‘burning sensation’; or it feels like someone squeezing the affected limb. People having CRPS generally experience change in skin color and temperature, and swelling in the affected area.
Get the detailed analysis @ https://www.pharmaproff.com/report/crps-therapeutics-pipeline-analysis
Axsome Therapeutics Inc., and Grünenthal Group are two major companies involved in the development of drugs for the management of CRPS. The Grünenthal Group is in the process of developing T121, a bone resorption inhibitor, for the treatment of CRPS. Axsome Therapeutics Inc. is also developing AXS-02 as a bone resorption factor inhibitor for the treatment of CRPS.
Make enquiry before purchase @ https://www.pharmaproff.com/enquiry/1096
• The report provides a comprehensive understanding of the pipeline activities covering all drug candidates under various stages of development, with the detailed analysis of pipeline and clinical trials.
• Pipeline analysis of drugs by phases includes product description and development activities including information about clinical results, designations, collaborations, licensing, grants, technology, and others.
About Us:
Pharma Proff, is a frontline market intelligence and consulting solutions provider catering to the information and data needs of burgeoning sectors across the world, including pharmaceutical and healthcare. With meticulously curated research reports on the industry landscape, we empower companies in the healthcare and pharmaceutical sectors to make informed business decisions and base their marketing strategies with astuteness.
Contact:
Pharma Proff
Toll-free: +1-888-778-7886 (USA/Canada)
International: +1-347-960-6455
Email: enquiry@pharmaproff.com
Web: https://www.pharmaproff.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Complex Regional Pain Syndrome (CRPS) Therapeutics Clinical Trials & Results | Axsome Therapeutics, Inc., Grünenthal Group here
News-ID: 1752003 • Views: …
More Releases for CRPS
Inside the Cycle of CRPS: Stella Artuso's Story of Resilience
Stella Artuso's condition seemed to be incurable until her parents found the Arkansas-based Spero Clinic. This is a one-of-a-kind facility specializing in treating conditions such as Complex Regional Pain Syndrome.
Image: https://www.globalnewslines.com/uploads/2025/04/b46865964236fed3bbd45c5bc89f50e1.jpg
"I always felt like I was present in moments, but I was separated by a barrier of pain. I couldn't smile without faking." - Stella Arturo.
Imagine being 12 years old, enjoying life, sports, running, and having a great time. Then,…
A New Chapter: The Spero Clinic Helps CRPS Patient Lou Reclaim Her Life
CRPS is causing constant, debilitating pain for people around the world. Here's what The Spero Clinic is doing to save lives from this dreadful disease.
Image: https://www.globalnewslines.com/uploads/2025/02/a3269782b20b4832d25263680ae9bac8.jpg
"I had absolute plans to kill myself because I just thought this is not a life that I want."
Statements such as these sound alarming, but the truth is that many patients suffering from Complex Regional Pain Syndrome (CRPS) end up feeling this way. Why?
Because CRPS,…
Paula's Journey: CRPS Survivor Finds Hope and Healing at the Spero Clinic
Paula, a survivor of Complex Regional Pain Syndrome (CRPS), shares her transformative journey toward healing at The Spero Clinic. CRPS is a chronic pain condition affecting millions, often triggered by an injury or medical event, causing severe pain, muscle spasms, and mobility issues.
Image: https://www.globalnewslines.com/uploads/2025/02/2ce8be74be632434741ecf707cfafe58.jpg
CRPS, or Complex Regional Pain Syndrome, is a chronic pain condition that affects between 5 and 8 million people around the world. CRPS [https://www.thesperoclinic.com/conditions/complex-regional-pain-syndrome/] is often triggered…
Award-Winning Director Charles Mattocks Teams Up with Scrambler Therapy for Grou …
Image: https://www.abnewswire.com/upload/2025/01/eb1c2b4539342e8dbad4e6c84149a2cf.jpg
Acclaimed director Charles Mattocks, known for his impactful films and TV programs focused on health-related content, has partnered with Scrambler Therapy, a pioneering company in the field of Technology for Effective Pain Relief, to feature their innovative treatment in his upcoming documentary on Complex Regional Pain Syndrome (CRPS). This documentary is the second installment of Mattocks' awardwinning series exploring rare and debilitating diseases, with a special focus on CRPS.
Mattocks'…
Complex Regional Pain Syndrome (CRPS) Market to expand at a 2.2% value CAGR by 2 …
The global complex regional pain syndrome (CRPS) market is expected to be worth US$ 101.9 million in 2022, rising to US$ 126.7 million by 2032. During the forecast period of 2022 to 2032, the market is expected to grow at a 2.2% CAGR.
Request Sample@ https://www.futuremarketinsights.com/reports/sample/rep-gb-1708
Complex Regional Pain Syndrome (CRPS) is a chronic condition that causes severe pain in legs, arms, feet, and hands or may involve the entire body. CRPS…
Analysis of COVID-19 Crisis-driven Growth Opportunities in Complex Regional Pain …
Complex regional pain syndrome is a debilitating chronic pain condition causing intense pain particularly in the arms, hands, legs, or feet. This syndrome is characterized by pain, swelling, vasomotor instability, limited range of motion, skin color changes and patchy bone demineralization. CRPS is often regarded to be caused as a result of malfunction of failure of peripheral and central nervous system and therefore also sometimes referred as reflex sympathetic dystrophy…
